SNP in Tumor Necrosis Factor-Alpha (−308 A/G) Gene ‎ Association with HCV Infected Thalassemia Patients
Malallah, H., Al-Shemmary, A., AlMmuhammady, M., Jaber, A., Al-Mashhadi, A. (2023). SNP in Tumor Necrosis Factor-Alpha (−308 A/G) Gene ‎ Association with HCV Infected Thalassemia Patients. EKB Journal Management System, 90(2), 2296-2302. doi: 10.21608/ejhm.2023.285691
Hiba A. Malallah; Athraa J. Al-Shemmary; Marwa H. AlMmuhammady; Adhwaa H. Jaber; Abbas R. Al-Mashhadi. "SNP in Tumor Necrosis Factor-Alpha (−308 A/G) Gene ‎ Association with HCV Infected Thalassemia Patients". EKB Journal Management System, 90, 2, 2023, 2296-2302. doi: 10.21608/ejhm.2023.285691
Malallah, H., Al-Shemmary, A., AlMmuhammady, M., Jaber, A., Al-Mashhadi, A. (2023). 'SNP in Tumor Necrosis Factor-Alpha (−308 A/G) Gene ‎ Association with HCV Infected Thalassemia Patients', EKB Journal Management System, 90(2), pp. 2296-2302. doi: 10.21608/ejhm.2023.285691
Malallah, H., Al-Shemmary, A., AlMmuhammady, M., Jaber, A., Al-Mashhadi, A. SNP in Tumor Necrosis Factor-Alpha (−308 A/G) Gene ‎ Association with HCV Infected Thalassemia Patients. EKB Journal Management System, 2023; 90(2): 2296-2302. doi: 10.21608/ejhm.2023.285691

SNP in Tumor Necrosis Factor-Alpha (−308 A/G) Gene ‎ Association with HCV Infected Thalassemia Patients

The Egyptian Journal of Hospital Medicine
Article 46, Volume 90, Issue 2, January 2023, Page 2296-2302  XML PDF (579.58 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2023.285691
View on SCiNiTO View on SCiNiTO
Authors
Hiba A. Malallah email ; Athraa J. Al-Shemmary; Marwa H. AlMmuhammady; Adhwaa H. Jaber; Abbas R. Al-Mashhadi
Abstract
Background: Hemoglobin can develop abnormally as a result of hereditary blood illnesses called ‎thalassemia that are inherited from a person's parents. Objective: The goal of this study was to identify the tumor necrosis factor alpha (TNF-α) A/G polymorphism and correlate ‎TNF-α serum levels with illness progression.
Patients and methods: ‎Eighty cases with beta-thalassemia who had been diagnosed at the thalassemia center at ‎Al-Zahra Hospital in Al-Najaf province‎, Iraq participated in a case-control study with 40 ‎healthy individuals serving as the control group. The 80 individuals were divided based on HCV status. From 50 seropositive hepatitis C virus (HCV) patients, 19 had IgG positivity, 15 had ‎IgM positivity, and 16 had both IgG and IgM positivity. All patients and the control group had blood samples taken. DNA from blood was taken ‎to be utilized in PCR to find the TNF-α A/G polymorphism. TNF-α levels were assessed using an ELISA test.
Results: The findings explained why HCV-infected individuals had high significant rates of thalassemia ‎than non-infected ones. The findings showed that in thalassemia patients, AA genotype ‎and A allele are risk factors for severity, whereas GG genotype and G allele are ‎protective factors for severity.
Conclusions: The findings showed that having an AA genotype increases your chance of contracting ‎HCV. This study also demonstrated a considerably higher level of TNF-α in thalassemia ‎patients compared to controls, as well as a significantly higher level of TNF-α in ‎thalassemia patients who also had HCV infection compared to controls and patients ‎without HCV infection.
 
Keywords
Thalassemia; TNF-α‎; SNP; HCV; PCR‎
Statistics
Article View: 104
PDF Download: 311